Definitive Healthcare (NASDAQ:DH) Updates Q2 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its second quarter 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.080-0.090 for the period, compared to the consensus estimate of 0.090. The company issued revenue guidance of $62.0 million-$63.5 million, compared to the consensus revenue estimate of $65.2 million. Definitive Healthcare also updated its FY 2024 guidance to 0.360-0.380 EPS.

Analyst Ratings Changes

Several research firms recently weighed in on DH. Barclays reduced their target price on shares of Definitive Healthcare from $11.00 to $7.00 and set an equal weight rating for the company in a research note on Thursday. Canaccord Genuity Group reduced their target price on shares of Definitive Healthcare from $10.00 to $8.00 and set a hold rating for the company in a research note on Wednesday. Stifel Nicolaus dropped their price target on shares of Definitive Healthcare from $11.00 to $9.50 and set a buy rating for the company in a research report on Wednesday. Morgan Stanley lowered shares of Definitive Healthcare from an overweight rating to an equal weight rating and dropped their price target for the stock from $11.50 to $9.00 in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of Definitive Healthcare from $10.00 to $7.00 and set a hold rating for the company in a research report on Thursday. Nine investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of Hold and a consensus target price of $9.94.

Definitive Healthcare Price Performance

Shares of NASDAQ DH traded down $0.18 during mid-day trading on Thursday, hitting $5.17. 3,323,524 shares of the stock were exchanged, compared to its average volume of 643,916. The company has a market cap of $608.97 million, a P/E ratio of -2.90, a PEG ratio of 6.12 and a beta of 1.41. The stock’s fifty day simple moving average is $7.61 and its two-hundred day simple moving average is $8.27. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. Definitive Healthcare has a twelve month low of $4.38 and a twelve month high of $12.45.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.02). The firm had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. As a group, analysts forecast that Definitive Healthcare will post 0.11 EPS for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.